Thank you so much. I sort of knew that, but it's startling to hear you say that there's a medication that most people haven't heard of that drops the chance of dying from an opioid event almost to zero. It's just incredible, so I want to keep talking about it.
You anticipated my next question, which is this: What are the common barriers that you see in your practice, or that your colleagues see, in offering buprenorphine? It sounds like the guidelines are not yet where they should be and that the ease of use for physicians and maybe the know-how or education for physicians are not quite where they should be. Are there patient-side barriers that you notice in your practice?
